Share on StockTwits

Epizyme (NASDAQ:EPZM) Insider Eric Hedrick sold 2,000 shares of the stock on the open market in a transaction that occurred on Monday, June 16th. The stock was sold at an average price of $26.42, for a total value of $52,840.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Epizyme (NASDAQ:EPZM) traded up 3.40% during mid-day trading on Wednesday, hitting $29.47. The stock had a trading volume of 343,466 shares. Epizyme has a 1-year low of $18.10 and a 1-year high of $45.72. The stock’s 50-day moving average is $23.2 and its 200-day moving average is $25.87. The company’s market cap is $969.1 million.

Epizyme (NASDAQ:EPZM) last posted its quarterly earnings results on Tuesday, May 13th. The company reported ($0.22) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.47) by $0.25. On average, analysts predict that Epizyme will post $-1.78 earnings per share for the current fiscal year.

Epizyme, Inc is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize personalized therapeutics for patients with genetically defined cancers.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.